posted on 2013-05-28, 00:00authored byBruce
Kevin Ford, Mark Hamza, Dallas L. Rabenstein
A series of N-substituted glycine
oligomers (peptoids) of varying
length and side chains was synthesized with the aim of producing peptidomimetics
that would bind with high affinity to heparin and thereby neutralize
its anticoagulant activity. To this end, a library of 29 peptoids
was synthesized using solid phase synthesis methodologies. The general
design of the peptoids was the repeating trimer sequence N(cationic side chain)-N(alkyl or benzyl side chain)-N(α-chiral side chain), where the monomers are N-substituted glycine residues bearing the indicated side
chains. The peptoids were designed to have a helical structure with
positively charged ammonium or guanidinium groups on side chains that
would interact electrostatically with negatively charged sites on
heparin. Binding of the peptoids by heparin was characterized by isothermal
titration calorimetry (ITC) and heparin affinity chromatography (HAC).
The secondary structure of the peptoids was characterized by circular
dichroism (CD) spectroscopy. The peptoid design was systematically
modified to produce peptoids with high affinity binding to heparin
as measured by the above methods, resulting in the synthesis of peptoids
with micromolar and sub-micromolar heparin-binding affinity. The efficacy
of selected peptoids as agents for neutralization of the anticoagulant
activity of heparin was assayed by the Coatest method, which measures
restoration of the activity of the serine protease factor Xa (FXa).
The results indicate that peptoids show promise as potential therapeutic
agents for neutralization of the anticoagulant activity of heparin.